Transcatheter Aortic Valve Replacement in Failed Transcatheter Bioprosthetic Valves

Giuseppe Tarantini*, Janarthanan Sathananthan, Tommaso Fabris, Uri Landes, Vinayak N. Bapat, Jaffar M. Khan, Luca Nai Fovino, Syed Zaid, Nicolas M. Van Mieghem, Azeem Latib, Ron Waksman, Ole De Backer, Toby Rogers, Lars Søndergaard, Gilbert H.L. Tang*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

49 Scopus citations

Abstract

Transcatheter aortic valve replacement (TAVR) is increasingly being performed in younger and lower surgical risk patients. Given the longer life expectancy of these patients, the bioprosthetic valve will eventually fail, and aortic valve reintervention may be necessary. Although currently rare, redo-TAVR will likely increase in the future as younger patients are expected to outlive their transcatheter bioprosthesis. This review provides a contemporary overview of the indications, procedural planning, implantation technique, and outcomes of TAVR in failed transcatheter bioprosthetic aortic valves.

Original languageEnglish
Pages (from-to)1777-1793
Number of pages17
JournalJACC: Cardiovascular Interventions
Volume15
Issue number18
DOIs
StatePublished - 26 Sep 2022

Keywords

  • redo-TAVR
  • transcatheter heart valve
  • valve in valve

Fingerprint

Dive into the research topics of 'Transcatheter Aortic Valve Replacement in Failed Transcatheter Bioprosthetic Valves'. Together they form a unique fingerprint.

Cite this